L1CAM and endometrial carcinoma: The expression of L1CAM (tissue microarrays, clone UJ127, dilution 1:30, cutoff 5%) was also studied in the endometrial carcinomas of 34 diabetic patients compared with 34 endometrial carcinomas of matched non-diabetic patients, since the first group is more frequently associated with lymph node metastasis [55].